company background image
300049 logo

Inner Mongolia Furui Medical Science SZSE:300049 Stock Report

Last Price

CN¥46.17

Market Cap

CN¥12.3b

7D

-4.0%

1Y

104.6%

Updated

27 Jul, 2024

Data

Company Financials +

Inner Mongolia Furui Medical Science Co., Ltd.

SZSE:300049 Stock Report

Market Cap: CN¥12.3b

300049 Stock Overview

Inner Mongolia Furui Medical Science Co., Ltd.

300049 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Inner Mongolia Furui Medical Science Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Inner Mongolia Furui Medical Science
Historical stock prices
Current Share PriceCN¥46.17
52 Week HighCN¥57.50
52 Week LowCN¥20.60
Beta-0.34
11 Month Change-9.11%
3 Month Change-10.35%
1 Year Change104.56%
33 Year Change186.24%
5 Year Change487.40%
Change since IPO355.10%

Recent News & Updates

Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

Jul 21
Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

May 24
With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Apr 29
We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Recent updates

Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

Jul 21
Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

May 24
With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Apr 29
We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Feb 28
Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Shareholder Returns

300049CN PharmaceuticalsCN Market
7D-4.0%-4.0%-2.8%
1Y104.6%-18.8%-21.0%

Return vs Industry: 300049 exceeded the CN Pharmaceuticals industry which returned -18.8% over the past year.

Return vs Market: 300049 exceeded the CN Market which returned -21% over the past year.

Price Volatility

Is 300049's price volatile compared to industry and market?
300049 volatility
300049 Average Weekly Movement5.8%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.0%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 300049 has not had significant price volatility in the past 3 months.

Volatility Over Time: 300049's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998703Guanyi Wangwww.fu-rui.com

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. It operates in two segments, pharmaceutical production and sales; and diagnostic equipment R&D, production and sales.

Inner Mongolia Furui Medical Science Co., Ltd. Fundamentals Summary

How do Inner Mongolia Furui Medical Science's earnings and revenue compare to its market cap?
300049 fundamental statistics
Market capCN¥12.28b
Earnings (TTM)CN¥131.28m
Revenue (TTM)CN¥1.23b

93.6x

P/E Ratio

9.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300049 income statement (TTM)
RevenueCN¥1.23b
Cost of RevenueCN¥317.70m
Gross ProfitCN¥916.77m
Other ExpensesCN¥785.49m
EarningsCN¥131.28m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 30, 2024

Earnings per share (EPS)0.49
Gross Margin74.26%
Net Profit Margin10.63%
Debt/Equity Ratio0%

How did 300049 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.